POGLUT2 and cancer: We further analyze the impact of POGLUT2 on survival and disease progression in pan-cancer; the results showed that POGLUT2 could affect the OS in ACC, BLCA, BRCA, HNSC, KICH, KIRC, LGG, LIHC, LUAD, MESO, PCPG, PRAD, and STAD; DSS in ACC, BLCA, BRCA, COAD, HNSC, KICH, LGG, LIHC, LUSC, MESO, PCPG, and PRAD, but not in other types of cancers; DFI in ACC, CHOL, PAAD, and PCPG; and PFI in ACC, BLCA, BRCA, HNSC, KICH, KIRC, LGG, LIHC, LUAD, MESO, and PRAD, but not in other types of cancers (Figures 3A–D).